Eli Lilly signed a deal worth up to $2.75 billion with Insilico Medicine in March 2026 for a portfolio of preclinical, AI-designed drug candidates, one of the largest AI-pharma partnerships to date, with only $115 million guaranteed upfront.
Hyodol, a ChatGPT-powered companion doll already used by roughly 12,000 elderly South Koreans living alone, registered with the FDA in late 2024 and is targeting a full US launch in 2026 to combat senior isolation and detect falls.
UnitedHealth says its AI-driven PreCheck and OptumReal platforms now approve 96% of prior authorizations on first submission and cut missing-information denials by 68%, even as the AMA and multiple states push back on AI-driven claims denials.
OSF HealthCare has expanded its use of Rapid AI's stroke-detection software from its flagship hospitals to OSF St. Joseph Medical Center in Bloomington and rural hospitals across its Illinois network, letting neurologists review brain scans on their phones and speed up treatment decisions.
French robotics company Wandercraft commercially launched Eve on September 17, 2026, the first FDA-cleared self-balancing personal exoskeleton available to wheelchair users with spinal cord injuries at any neurological level, powered by AI trained on billions of simulated and real-world steps.
The FDA has granted 510(k) clearance to iHealthScreen's iPredict-DR, an AI screening tool paired with the iCare DRSplus fundus camera that lets primary care staff detect diabetic retinopathy without an ophthalmologist on site.
The FDA has cleared the Targeted Real-Time Early Warning System (TREWS), an AI tool born out of Johns Hopkins research and commercialized by Bayesian Health, marking the first authorized device that flags sepsis risk before clinicians even suspect it, with data showing an 18% cut in in-hospital mortality across dozens of U.S. hospitals.
Boston-based GenHealth.ai has raised a $16.5 million Series A led by Flare Capital Partners to expand its AI agents that automate prior authorization, billing, denials, and appeals for medical practices, bringing its total funding to $30 million.
Youper, an AI-powered emotional health app founded in 2016 that grew to more than 3 million users, will stop working on September 30, 2026 and delete all user data October 1 after years without meaningful funding beyond a single 2019 seed round.
Oura's integration with Counsel Health lets ring members chat with medical AI and escalate to a licensed physician inside the app, and on September 17, 2026 Counsel said it will extend AI-native chronic-care management to Medicare beneficiaries through the CMS ACCESS Model starting in early 2027.